SARCOIDOSIS
Clinical trials for SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SARCOIDOSIS trials appear
Sign up with your email to follow new studies for SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sarcoidosis drug study halted after just 3 patients
Disease control TerminatedThis study tested whether the drug maraviroc could reduce inflammation in the lungs of people with active sarcoidosis. Participants took the drug for 6 weeks and had two lung exams (bronchoscopy) to measure immune cells before and after treatment. Only 3 people enrolled, and the …
Matched conditions: SARCOIDOSIS
Phase: NA • Sponsor: Kevin F. Gibson • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New PET tracer aims to spot hidden inflammation in cancer and heart disease
Diagnosis TerminatedThis study tested a special imaging agent (68GaNOTA-anti-MMR-VHH2) that uses PET scans to find certain immune cells (macrophages) in the body. It included 29 adults with head and neck cancer, atherosclerosis, lymphoma, or sarcoidosis. The goal was to see if this scan could help p…
Matched conditions: SARCOIDOSIS
Phase: PHASE2 • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Jun 12, 2026 12:06 UTC
-
Sarcoidosis drug study fizzles: only 2 patients enrolled
Symptom relief TerminatedThis study tested whether Acthar gel could improve symptoms and lung function in people with sarcoidosis, a disease that causes inflammation in the lungs. Researchers also checked if a blood marker called CXCL9 dropped with treatment. Only 2 people joined before the study was sto…
Matched conditions: SARCOIDOSIS
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 12, 2026 12:06 UTC